Skip to content

8-KAccepted Dec 9, 9:17 AM ET

Revance Therapeutics, Inc. 8-K

Revance Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

9:17 AM

Dec 9, 2024

Filed

Dec 9, 2024

Documents

17

Size

1.5 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.